Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its advanced ...

A possible cluster of bird flu infections has grown to include eight people, in what may be the first examples of ...

Respiratory syncytial virus (RSV ... Key exclusion criteria were positivity for the human immunodeficiency virus, concurrent influenza virus infection or bacterial pneumonia, and known or ...

Poynter has partnered with the Risk Less. Do More. campaign to host a webinar, articles to better inform journalists.

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV ...

The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are ...

Health officials in North Dakota are encouraging state residents to prepare for the upcoming respiratory illness season.

Watertown, Massachusetts Saturday, September 28, 2024, 18:00 Hrs [IST] ...

Vicebio has secured $100mn in Series B funding to further develop its vaccines for multiple respiratory infections.

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...